40 related articles for article (PubMed ID: 2186820)
21. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.
Rosenfeld ME; Ylä-Herttuala S; Lipton BA; Ord VA; Witztum JL; Steinberg D
Am J Pathol; 1992 Feb; 140(2):291-300. PubMed ID: 1739123
[TBL] [Abstract][Full Text] [Related]
22. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
Qi CF; Nieroda C; De Filippi R; Greiner JW; Correale P; Schlom J; Tsang KY
Immunol Lett; 1995; 47(1-2):15-24. PubMed ID: 8537095
[TBL] [Abstract][Full Text] [Related]
23. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
Munn DH; Cheung NK
J Exp Med; 1989 Aug; 170(2):511-26. PubMed ID: 2526848
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells.
Munn DH; Bree AG; Beall AC; Kaviani MD; Sabio H; Schaub RG; Alpaugh RK; Weiner LM; Goldman SJ
Blood; 1996 Aug; 88(4):1215-24. PubMed ID: 8695839
[TBL] [Abstract][Full Text] [Related]
25. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
Schmid I; Baldwin GC; Jacobs EL; Isacescu V; Neagos N; Giorgi JV; Glaspy JA
Cytometry; 1995 Jun; 22(2):103-10. PubMed ID: 7587740
[TBL] [Abstract][Full Text] [Related]
26. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
Kushner BH; Cheung NK
Blood; 1989 May; 73(7):1936-41. PubMed ID: 2653466
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte-macrophage colony stimulating factor in autologous bone marrow transplantation: augmentation of graft versus tumor effect via antibody dependent cellular cytotoxicity.
Charak BS; Sadowski RM; Mazumder A
Leuk Lymphoma; 1993 Apr; 9(6):453-7. PubMed ID: 8339051
[TBL] [Abstract][Full Text] [Related]
28. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
Munn DH; Garnick MB; Cheung NK
Blood; 1990 May; 75(10):2042-8. PubMed ID: 2186820
[TBL] [Abstract][Full Text] [Related]
29. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).
VandePol CJ; Garnick MB
Biotechnol Ther; 1991; 2(3-4):231-9. PubMed ID: 1845128
[TBL] [Abstract][Full Text] [Related]
30. Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6.
Garnick MB; O'Reilly RJ
Hematol Oncol Clin North Am; 1989 Sep; 3(3):495-509. PubMed ID: 2698879
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
